ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer.

导出 OA

翻译打印收藏纠错

作者： Sunho,Park ^[1] ; John D,Karalis ^[2] ; Changjin,Hong ^[1] ; Jean R,Clemenceau ^[1] ; Matthew R,Porembka ^[2] ; In-Ho,Kim ^[3] ; Sung Hak,Lee ^[4] ; Sam C,Wang ^[2] ; Jae-Ho,Cheong ^[5] ; Tae Hyun,Hwang ^[6]

作者单位： Department of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, Florida. ^[1] Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas. ^[2] Department of Internal Medicine, Division of Medical Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[3] Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. ^[4] Department of Surgery, Yonsei University College of Medicine, Seoul, South Korea. ^[5] Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul, South Korea. ^[6] Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea. ^[7] Department of Immunology, Mayo Clinic, Jacksonville, Florida. ^[8] Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida. ^[9]

主题词人类(Humans);胃肿瘤(Stomach Neoplasms);回顾性研究(Retrospective Studies);微卫星不稳定性(Microsatellite Instability);肌动蛋白类(Actins)

DOI 10.1158/1078-0432.CCR-22-1897

PMID 36508166

发布时间 2023-09-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交